Cochrane Abstracts
Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Adjuvant Chemotherapy After Concurrent Chemoradiation for Locally Advanced Cervical Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435291/all/Adjuvant_chemotherapy_after_concurrent_chemoradiation_for_locally_advanced_cervical_cancer_Edited__no_change_to_conclusions_.
Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435291/all/Adjuvant_chemotherapy_after_concurrent_chemoradiation_for_locally_advanced_cervical_cancer_Edited__no_change_to_conclusions_. Accessed December 13, 2024.
Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435291/all/Adjuvant_chemotherapy_after_concurrent_chemoradiation_for_locally_advanced_cervical_cancer_Edited__no_change_to_conclusions_
Adjuvant Chemotherapy After Concurrent Chemoradiation for Locally Advanced Cervical Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435291/all/Adjuvant_chemotherapy_after_concurrent_chemoradiation_for_locally_advanced_cervical_cancer_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer
ID - 435291
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435291/all/Adjuvant_chemotherapy_after_concurrent_chemoradiation_for_locally_advanced_cervical_cancer_Edited__no_change_to_conclusions_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
